Innoforce names Dewan Zeng as the new CEO

Con­tract de­vel­op­er and man­u­fac­tur­er In­no­force is mak­ing changes at the top. The CD­MO named De­wan Zeng as its new CEO, ef­fec­tive im­me­di­ate­ly. For­mer CEO Yul­ing Li will stay on as pres­i­dent, fo­cus­ing specif­i­cal­ly on op­er­a­tions, ac­cord­ing to a Tues­day press re­lease.

Zeng most re­cent­ly served as the glob­al head of search and eval­u­a­tion, busi­ness de­vel­op­ment at BeiGene, and be­fore that, as the se­nior di­rec­tor of clin­i­cal ser­vices, ac­cord­ing to her LinkedIn pro­file. In the most re­cent role at BeiGene, she worked on deals be­tween the com­pa­ny and oth­er phar­mas. She al­so held roles at Pfiz­er, Gilead Sci­ences and CV Ther­a­peu­tics be­fore BeiGene.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters